The use of thiamine and thiamine antagonists to investigate the etiology of early mortality syndrome in lake trout (Salvelinus namaycush).
Early mortality syndrome (EMS) is a non-infectious disease affecting lake trout and other salmonids in the Great Lakes and in inland lakes. It is characterised by loss of equilibrium, hyperexcitability, anorexia, and eventually death. EMS is associated with low thiamine and treatment of eggs or fry with thiamine-HCl eliminates symptoms and mortality. To verify the role of the active form of the vitamin as the prophylactic agent, we used thiamine pyrophosphate (TPP) to reverse EMS symptoms. We also investigated the ability of specific thiamine antagonists that either block TPP production or interfere with its function to induce EMS. When graded doses of TPP were administered to EMS-susceptible sac-fry, there was a dose-dependent reduction in EMS. The egg concentration of TPP that was associated with reduced EMS was similar to the threshold thiamine concentration found in feral lake trout stocks where EMS occurs. A thiamine deficient stock from Lake Ontario was very sensitive to the thiamine antagonist oxythiamine (OXY) with total mortality associated with developmental arrest occurring at an antagonist to thiamine molar ratio (ATR) above 7:1. The threshold ATR with OXY for development of EMS-like neurological signs in this stock was 1.6:1. In addition to EMS-like neurological signs, OXY caused dose-dependent increases in hydrocephalus, developmental arrest, and vitelline congestion in the Lake Ontario stock. These signs are consistent with those observed in feral fish exhibiting EMS. Much higher doses of antagonists were required (both pyrithiamine (PT) and OXY) to induce EMS-like clinical signs in the thiamine replete Lake Manitou stock. PT was a more potent inducer in this stock as the ATR associated with development of clinical signs was 111:1 for PT compared with 892:1 for OXY. These data provide experimental evidence supporting the hypothesis that a thiamine deficiency in the natural environment is the cause of EMS.
Fitzsimons
J D
JD
Fisheries and Oceans Canada, Bayfield Institute, Ont., L7R 4A6, Burlington, Canada.
Vandenbyllaardt
L
L
Brown
S B
SB
D000818:Animals; D005260:Female; D005393:Fish Diseases / Q000209:etiology* / Q000401:mortality; D005618:Fresh Water; D006114:Great Lakes Region; D008297:Male; D010119:Oxythiamine; D011745:Pyrithiamine; D013836:Thiamin Pyrophosphokinase / Q000378:metabolism; D013831:Thiamine / Q000037:antagonists & inhibitors*; D013835:Thiamine Pyrophosphate; D014337:Trout
D010119:Oxythiamine; D011745:Pyrithiamine; D013836:Thiamin Pyrophosphokinase; D013835:Thiamine Pyrophosphate; D013831:Thiamine